Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (8): 38-43.doi: 10.6040/j.issn.1671-7554.0.2021.0935
Previous Articles Next Articles
GUO Yunfei, SHU Qiang
CLC Number:
[1] Eudy AM, Siega-Riz AM, Engel SM, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2018, 77(6): 855-860. [2] Sugawara E, Kato M, Fujieda Y, et al. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan[J]. Lupus, 2019, 28(12): 1407-1416. [3] 复发性流产合并风湿免疫病免疫抑制剂应用中国专家共识编写组. 复发性流产合并风湿免疫病免疫抑制剂应用中国专家共识[J]. 中华生殖与避孕杂志, 2020, 40(7): 527-534. [4] 自然流产诊治中国专家共识编写组.自然流产诊治中国专家共识(2020年版)[J]. 中国实用妇科与产科杂志, 2020, 36(11): 1082-1090. [5] Chen Y, Wu Q, Wei J, et al. Effects of aspirin, vitamin D3, and progesterone on pregnancy outcomes in an autoimmune recurrent spontaneous abortion model[J]. Braz J Med Biol Res, 2021, 54(9): e9570. doi: 10.1590/1414-431X2020e9570. [6] Ceccarelli F, Pirone C, Perricone C, et al. Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis[J]. Rheumatology(Oxford), 2021, 60(4): 1747-1754. [7] Hiramatsu Y, Isoda K, Kotani T, et al. Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus[J]. Arthritis Res Ther, 2021, 23(1): 140. doi: 10.1186/s13075-021-02522-x. [8] Zhang S, Wu Z, Zhang W, et al. Clinical performance of non-criteria antibodies to phospholipids in Chinese patients with antiphospholipid syndrome[J]. Clin Chim Acta, 2019, 495: 205-209. doi: 10.1016/j.cca.2019.04.065. [9] Nalli C, Lini D, Andreoli L, et al. Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies[J]. Biomedicines, 2021, 9(6): 671. doi: 10.3390/biomedicines9060671. [10] Cohen H, Efthymiou M, Devreese KMJ. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome[J]. J Thromb Haemost, 2021, 19(4): 892-908. [11] Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases[J]. Arthritis Rheumatol, 2020, 72(4): 529-556. [12] Bröms G, Kieler H, Ekbom A, et al. Anti-TNF treatment during pregnancy and birth outcomes: a population-based study from Denmark, Finland, and Sweden[J]. Pharmacoepidemiol Drug Saf, 2020, 29(3): 316-327. [13] Elliott B, Spence AR, Czuzoj-Shulman N, et al. Effect of Sjögrens syndrome on maternal and neonatal outcomes of pregnancy[J]. J Perinat Med, 2019, 47(6): 637-642. [14] Spinillo A, Beneventi F, Ramoni V, et al. Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy[J]. Annals of the Rheumatic Diseases, 2012, 71(6): 918-923. [15] Zucchi D, Tani C, Monacci F, et al. Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies[J]. Rheumatology(Oxford), 2020, 59(6): 1335-1339. [16] de Moreuil C, Alavi Z, Pasquier E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage[J]. Br J Clin Pharmacol, 2020, 86(1): 39-49. [17] Duan J, Ma D, Wen X, et al. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis[J]. Lupus, 2021, 30(7): 1163-1174. [18] Yang S, Ni R, Lu Y, et al. A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses(ILIFE)trial[J]. Trials, 2020, 21(1): 771. doi: 10.1186/s13063-020-04716-1. [19] Dong Y, Lu Y, Xia Y, et al. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis[J]. J Matern Fetal Neonatal Med, 2021: 1-9. doi: 10.1080/14767058.2021.1943656. [20] Ou H, Yu Q. Efficacy of aspirin, prednisone, and multivitamin triple therapy in treating unexplained recurrent spontaneous abortion: a cohort study[J]. Int J Gynaecol Obstet, 2020, 148(1): 21-26. [21] Ince-Askan H, van den Akker ELT, de Rijke YB, et al. Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort study[J]. RMD Open, 2019, 5(1): e000852. doi: 10.1136/rmdopen-2018-000852. [22] De Cock D, Brants L, Soenen I, et al. A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis[J]. Semin Arthritis Rheum, 2020, 50(5): 873-878. [23] Huang W, Lu W, Li Q, et al. Effects of cyclosporine A on proliferation, invasion and migration of HTR-8/SVneo human extravillous trophoblasts[J]. Biochem Biophys Res Commun, 2020, 533(4): 645-650. [24] Sharma UR, Rathnakaran AN, Raj BPP, et al. The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy[J]. Inflammopharmacology, 2021, 29(4): 987-1000. [25] Balbi GGM, Domingues V, Balbi GGM, et al. Use of synthetic and biologic DMARDs during pregnancy[J]. Expert Rev Clin Immunol, 2019, 15(1): 27-39. [26] Ponticelli C, Moroni G. Fetal toxicity of immunosuppressive drugs in pregnancy[J]. J Clin Med, 2018, 7(12): 552. doi: 10.3390/jcm7120552. [27] Yang X, Meng T. Is there a role of intravenous immunoglobulin in immunologic recurrent pregnancy loss?[J]. J Immunol Res, 2020, 2020: 6672865. doi: 10.1155/2020/6672865. [28] Urban ML, Bettiol A, Serena C, et al. Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: a case series and systematic review of literature[J]. Autoimmun Rev, 2020, 19(9): 102620. doi: 10.1016/j.autrev.2020.102620. [29] Prieto-Peña D, Calderón-Goercke M, Adán A, et al. Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy[J]. Clin Exp Rheumatol, 2021, 39(1): 105-114. [30] Perrotta K, Kiernan E, Bandoli G, et al. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series[J]. Rheumatol Adv Pract, 2021, 5(1): rkaa074. doi: 10.1093/rap/rkaa074. [31] Saito J, Yakuwa N, Kaneko K, et al. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum[J]. Rheumatology(Oxford), 2019, 58(8): 1505-1507. [32] Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(6): 736-745. [33] Akhlaghi M, Kianersi F, Radmehr H, et al. Evaluation of optical coherence tomography angiography parameters in patients treated with Hydroxychloroquine[J]. BMC Ophthalmol, 2021, 21(1): 209. doi: 10.1186/s12886-021-01977-5. |
[1] | CHENG Xuan, YANG Fan, PAN Zhenglun. Systemic lupus erythematosus, antiphospholipid syndrome with cerebral venous sinus thrombosis: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 70-74. |
[2] | ZHAO Bingqing, GAO Xuan, LI Jiangxia. A retrospective analysis of chromosome karyotypes in RSA couples from assisted reproductive population [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 26-31. |
[3] | WANG Baihui, SONG Yanjun, ZHANG Shuaiqing, ZUO Xiuli, WANG Qing, ZHANG Aijun, LI Ruyuan. Three cases of amyloidosis with diarrhea as the first symptom and literature review [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 93-97. |
[4] | XU Daxia, HOU Nan, LI Xiaofeng, WANG Chuang, KONG Meng, JIAO Guangjun, CHEN Yunzhen. Relevance between bone metabolism of glucocorticoid-induced osteoporosis and duration of glucocorticoid treatment [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 103-107. |
[5] | DU Jinge, CHEN Hui, YANG Xiaorong, LÜ Ming. Meta-analysis of the association between the STAT4 rs7574865 polymorphism and systemic lupus erythematosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 95-102. |
[6] | MA Zhenzhen, SUN Hongsheng, YANG Qingrui. Changes and clinical significance of serum adipokines in systemic lupus erythematosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 86-90. |
[7] | LI Jian, XU Bing, YAN Xinfeng, XU Wanju, CHANG Xiaotian. Screening key genes for TXNDC5 and insulin signaling pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 88-93. |
[8] | GAI Linlin, GUAN Lixue, LI Haibo, CHU Jinjin, ZHU Yun, LI Ming. Screening results and influencing factors of T-SPOT.TB assay in patients with autoimmune rheumatic diseases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(6): 82-86. |
[9] | JIA Xinzhuan, ZHANG Na, GUO Lina, ZHAO Suying, DONG Cui, WEI Lan. Effects of prednisone therapy on the clinical outcomes and phenotypes of natural killer cells in patients with URSA [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 62-65. |
[10] | ZHAO Yan, ZHENG Yabing, YAN Xinfeng, ZHANG Hu, CHANG Xiaotian. Screening crucial genes for glucose metabolism in rheumatoid arthritis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 30-35. |
[11] | JIANG Huiyu, WANG Lin, PAN Jihong. Effects of PCSK6 silence by siRNA on FLS in CIA [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 20-26. |
[12] | ZHENG Jiatian, ZHU Kai, SUN Hongsheng, FU Min, PAN Zhenglun. Association of IL-18 and MCP-1 gene polymorphisms with rheumatoid arthritis: a meta-analysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 98-104. |
[13] | JIA Qiuhua, YU Fei. Expression of T cell immunoglobulin mucin-3 in villous and decidual tissues of patients with unexplained recurrent spontaneous abortion [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 81-85. |
[14] | LI Feng1, XU Jing2, ZHENG Jia-tian1, ZHANG Yuan-chao1, SUN Hong-sheng1, PAN Zheng-lun1. Association between CD14 gene polymorphisms and rheumatoid arthritis in Han population of Shandong province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 87-91. |
[15] | WEI Chao1, WU Wei-ping1, ZHAO Yan1, WANG Lin1, YAN Xin-feng2, CHANG Xiao-tian1 . Effects of estrogen on the disease development in the collagen-induced arthritis animal models [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(8): 54-59. |
|